Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Archer

Showing results (11-20 of 115) with videos related to

Pageof 12
Sort By:
Obstetrics and Gynecology Clinics of North America|December 1, 1987
Current concepts and treatment of hyperprolactinemiaD F Archer
Fertility and Sterility|April 1, 1987
Prolactin response to thyrotropin-releasing hormone in women with infertility and/or randomly elevated serum prolactin levelsD F Archer
Contraception|January 20, 2000
Endometrial histology during use of a low-dose estrogen-desogestrel oral contraceptive with a reduced hormone-free intervalD F Archer
Menopause (New York, N.Y.)|July 13, 2001
The effect of the duration of progestin use on the occurrence of endometrial cancer in postmenopausal womenD F Archer
Journal of Women'S Health|June 5, 1998
Case report: Endometrial carcinoma after endometrial resection for menorrhagiaD F Archer
Clinical Obstetrics and Gynecology|June 1, 1996
Mifepristone: a potential contraceptiveO Heikinheimo, D F Archer
Climacteric : the Journal of the International Menopause Society|May 23, 2012
Estrogen and progestogen effect on venous thromboembolism in menopausal womenD F Archer, E Oger
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 1, 1974
Ultrastructural changes of the human corpus luteum of pregnancy induced by prostaglandin E2 in vitroH Salazar, D F Archer
Clinical Obstetrics and Gynecology|September 1, 1981
The fallacy of the postpill amenorrhea syndromeD F Archer, R L Thomas
Fertility and Sterility|July 1, 1974
Metabolism of estradiol-6,7-3H by the human fallopian tube. I. Effects of prostaglandin F2alpha in vitroR L Fronduti, D F Archer
Pageof 12

Showing results (11-20 of 115) with videos related to

Sort By:
Pageof 12
Obstetrics and Gynecology Clinics of North America|December 1, 1987
Current concepts and treatment of hyperprolactinemiaD F Archer
Fertility and Sterility|April 1, 1987
Prolactin response to thyrotropin-releasing hormone in women with infertility and/or randomly elevated serum prolactin levelsD F Archer
Contraception|January 20, 2000
Endometrial histology during use of a low-dose estrogen-desogestrel oral contraceptive with a reduced hormone-free intervalD F Archer
Menopause (New York, N.Y.)|July 13, 2001
The effect of the duration of progestin use on the occurrence of endometrial cancer in postmenopausal womenD F Archer
Journal of Women'S Health|June 5, 1998
Case report: Endometrial carcinoma after endometrial resection for menorrhagiaD F Archer
Clinical Obstetrics and Gynecology|June 1, 1996
Mifepristone: a potential contraceptiveO Heikinheimo, D F Archer
Climacteric : the Journal of the International Menopause Society|May 23, 2012
Estrogen and progestogen effect on venous thromboembolism in menopausal womenD F Archer, E Oger
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 1, 1974
Ultrastructural changes of the human corpus luteum of pregnancy induced by prostaglandin E2 in vitroH Salazar, D F Archer
Clinical Obstetrics and Gynecology|September 1, 1981
The fallacy of the postpill amenorrhea syndromeD F Archer, R L Thomas
Fertility and Sterility|July 1, 1974
Metabolism of estradiol-6,7-3H by the human fallopian tube. I. Effects of prostaglandin F2alpha in vitroR L Fronduti, D F Archer
Pageof 12